TMO
Thermo Fisher Scientific Inc.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$608.30
−1.64%Forward multiples
Based on analyst estimates
- P/E forward
- 23.18x
- P/E 2026E
- 24.35x
- P/E 2027E
- 22.31x
- P/E 2028E
- 20.25x
- P/S forward
- 4.59x
Trailing multiples
Trailing twelve months
- P/E TTM
- 32.67x
- PEG TTM
- 0.80x
- Price / book
- 4.27x
- Price / sales
- 4.85x
- Price / cash flow
- 24.95x
Enterprise value
- Enterprise value
- $263.4B
- EV / sales
- 5.68x
- EV / EBITDA
- 24.09x
- EV / EBIT
- 32.14x
- Market cap
- $224.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026